地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:13212737804
邮箱:sales@amyjet.com

<| 产品名称 | 货号 | 化学式 | 分子量 | CAS# |
| 2,5-Anhydro-6-azido-6-deoxy-1,3-O-isopropylidene-D-glucitol | S20031 | C9H15N3O4 | 229,23 | N/A |
| 4-Azido-4-deoxy-1,6:2,3-dianhydro-β-D-mannopyranose | S97085 | C7H9N3O2 | 167,17 | N/A |
| Methyl-3,6-anhydro-7-azido-2,7-dideoxy-4,5-O-isopropylidene-D-alloheptonate | S10191 | C11H17H3O5 | 271,27 | N/A |
| 1,4-Anhydro-3-azido-2-O-benzoyl-3-deoxy-D-xylitol | S10192 | C12H13N3O4 | 263,25 | N/A |
| 1,4-Anhydro-2-azido-3-O-benzoyl-2-deoxy-D-arabitol | S10189 | C12H13N3O4 | 263,25 | N/A |
| 2-Azido-2-deoxy-1,4;3,6-dianhydro-D-glucitol | S03293 | C6H9N3O3 | 171,15 | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-D-galactopyranose | S05174 | C14H19N3O9 | 373,32 | N/A |
| 6-Azido-6-deoxy-1,2,3,4-tetra-O-acetyl-α,β-L-galactopyranose | S02174 | C14H19N3O9 | 373,32 | N/A |
| DIBMA free acid | D-20054 | N/A | N/A | N/A |
| DIBMA monosodium salt | D-20055 | N/A | N/A | N/A |
| Glyco-DIBMA | D-20056 | N/A | N/A | N/A |
| n-Octyl α-D-glucopyranoside (aOG) > 99% highly purified | D97011 | C14H28O6 | 292,38 | 29781-80-4 |
| Methyl 6-O-(-n-heptylcarbamoyl)-α-D-glucopyranoside (HECAMEG) | D20034 | C15H29NO7 | 335,4 | 115457-83-5 |
| n-Hexyl β-D-glucopyranoside > 99% highly purified | D99014 | C12H24O6 | 264,4 | 59080-45-4 |
| n-Heptyl β-D-glucopyranoside (HeptG) > 99% highly purified | D07033 | C13H26O6 | 278,4 | 78617-12-6 |
| n-Octyl β-D-glucopyranoside (OG) > 99% highly purified | D97001 | C14H28O6 | 292,38 | 29836-26-8 |
| n-Octyl β-D-glucopyranoside (OG-C) > 99,5% for crystallography | D97001-C | C14H28O6 | 292,38 | 29836-26-8 |
| n-Nonyl β-D-glucopyranoside (NG) > 99% highly purified | D99011 | C15H30O6 | 306,40 | 69984-73-2 |
| n-Nonyl β-D-glucopyranoside (NG-C) > 99,5% for crystallography | D99011-C | C15H30O6 | 306,40 | 69984-73-2 |
| n-Decyl β-D-glucopyranoside (DG) > 99% highly purified | D99006 | C16H32O6 | 320,43 | 58846-77-8 |
| n-Undecyl β-D-glucopyranoside (UDG) > 99% highly purified | D11023 | C17H34O6 | 334,4 | 70005-86-6 |
| n-Dodecyl β-D-glucopyranoside (DDG) > 99% highly purified | D99007 | C18H36O6 | 348,5 | 59122-55-3 |
| 4-trans-(4-trans-Propylcyclohexyl)-cyclohexyl α-maltoside > 99% (t-PCCαM) | D99019-C | C27H47O11 | 547,67 | N/A |
| n-Dodecyl α-maltoside (αDDM) > 99% highly purified | D99020 | C24H46O11 | 510,63 | 116183-64-3 |
| n-Hexyl β-maltoside (HexM) > 99% highly purified | D20018 | C18H34O11 | 426,4 | 870287-95-9 |
| n-Heptyl β-maltoside (HeptM) > 99% highly purified | D14001 | C19H36O11 | 440,48 | N/A |
| n-Octyl β-maltoside (OM) > 99% highly purified | D20020 | C20H38O11 | 454,4 | 82494-08-4 |
| n-Nonyl β-maltoside (NM) > 99% highly purified | D20015 | C21H40O11 | 468,41 | 106402-05-5 |
| n-Nonyl β-maltoside (NM-C) > 99,5% for crystallography | D20015-C | C21H40O11 | 468,41 | 106402-05-5 |
| n-Decyl β-maltoside (DM) > 99% highly purified | D99003 | C22H42O11 | 482,6 | 82494-09-5 |
| n-Decyl β-maltoside (DM-C) > 99,5% for crystallography | D99003-C | C22H42O11 | 482,6 | 82494-09-5 |
| n-Undecyl β-maltoside (UDM) > 99% highly purified | D99012 | C23H44O11 | 496,6 | 253678-67-0 |
| n-Undecyl β-maltoside (UDM-C) > 99,5% for crystallography | D99012-C | C23H44O11 | 496,6 | 253678-67-0 |
| n-Dodecyl β-maltoside (DDM-C) > 99,5% for crystallography | D97002-C | C24H46O11 | 510,63 | 69227-93-6 |
| n-Tridecyl β-maltoside (TDM) > 99% | D20016 | C25H48O11 | 524,6 | 93911-12-7 |
| n-Tridecyl β-maltoside (TDM-C) > 99,5% for crystallography | D20016-C | C25H48O11 | 524,6 | 93911-12-7 |
| n-Tetradecyl β-maltoside (TeDM-C) > 99,5% for crystallography | D20028-C | C26H50O11 | 538,6 | 18449-82-6 |
| n-Pentadecyl β-maltoside (PDM-C) > 99,5% for crystallography | D20040-C | C27H52O11 | 552,35 | N/A |
| n-Hexadecyl β-maltoside (HeDM) > 99,5% | D20029-C | C28H54O11 | 566,72 | 98064-96-1 |
| n-Dodecyl β-maltoside (DDM) > 99% highly purified | D97002 | C24H46O11 | 510,63 | 69227-93-6 |
| Isopropyl 1-thio-β-D-galactopyranoside (IPTG) | S02122 | C9H18O5 | 238,30 | 367-93-1 |
| n-Heptyl 1-thio-β-D-glucopyranoside (HTG) > 99% highly purified | D99013 | C13H26O5S | 294,4 | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside (OTG) > 99% highly purified | D20014 | C14H28O5S | 308,44 | 85618-21-9 |
| n-Nonyl 1-thio-β-D-glucopyranoside (NTG-C) > 99,5% highly purified | D14038-C | C15H30O5S | 322,4 | 98854-15-0 |
| n-Decyl 1-thio-β-D-glucopyranoside (DTG) > 99% highly purified | D20021 | C16H32O5S | 336,4 | 98854-16-1 |
| n-Dodecyl 1-thio-β-maltoside (DDTM-C) > 99,5% highly purified | D20022-C | C24H46O10S | 526,6 | 148565-58-6 |
| n-Heptyl 1-thio-β-D-glucopyranoside (HTG-C) > 99,5% highly purified | D99013-C | C13H26O5S | 294,4 | 85618-20-8 |
| n-Octyl 1-thio-β-D-glucopyranoside (OTG-C) > 99,5% highly purified | D20014-C | C14H28O5S | 308,44 | 85618-21-9 |
| MEGA-8 (N-Octanoyl-N-methylglucamin) | D98004 | C15H31NO6 | 321,4 | 85316-98-9 |
| MEGA-9 (N-Nonanoyl-N-methylglucamin) | D99005 | C16H33NO6 | 335,4 | 85261-19-4 |
| MEGA-10 (N-Decanoyl-N-methylglucamin) | D99008 | C16H33NO6 | 335,4 | 85261-19-4 |
| 1-O-(n-Octyl)-tetraethyleneglycol (C8E4) | D20038 | C16H34O5 | 306,44 | 19327-39-0 |
| 1-O-(n-Decyl)-hexaethyleneglycol (C10E6) | D20041 | C22H46O7 | 422,60 | 5168-89-8 |
| 1-O-(n-Decyl)-nonaethyleneglycol (C10E9) | D20033 | C28H58O10 | 554,75 | 26183-52-81 |
| 1-O-(n-Dodecyl)-tetraethyleneglycol (C12E4) | D20035 | C20H42O5 | 362,54 | 5274-68-0 |
| 1-O-(n-Dodecyl)-octaethyleneglycol (C12E8) | D20039 | C28H58O9 | 538,75 | 3055-98-9 |
| 1-O-(n-Dodecyl)-nonaethyleneglycol (C12E9) | D20032 | C30H62O10 | 582,81 | 3055-99-0 |
| 1-O-(n-Dodecyl)-decaethyleneglycol (C12E10) | D20031 | C32H66O11 | 626,86 | 6540-99-4 |
| 1-O-(n-Tridecyl)-octaethyleneglycol (C13E8) | D20030 | C29H60O9 | 552,78 | 9043-30-5 |
| N,N-Dimethyl-n-dodecylamine-N-oxide (LDAO) | D71111 | C14H31NO | 229,4 | 1643-20-5 |
| Sucrose monolaurate (SUMOL) | S98001 | C24H44NO12 | 524,6 | 25339-99-5 |
| Monoolein (1-O-Oleoyl-rac-glycerol) | D20036 | C21H40O4 | 356,5 | 111-03-5 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-1-propane sulfonate | D99009 | C32H58N2O7S | 614,89 | 75621-03-3 |
| 3-[(3-Cholamidopropyl)-dimethylammonio]-2-hydroxy-1-propane sulfonate | D99010 | C32H58N2O8S | 630,87 | 82473-24-3 |
| n-Nonyl-phosphocholine (C9-PC) Purity > 99% | S10197 | C14H32NO4P | 309,38 | 253678-64-7 |
| n-Decyl-phosphocholine (C10-PC) Purity > 99% | S10195 | C15H34NO4P | 323,41 | 70504-28-8 |
| n-Undecyl-phosphocholine (C11-PC) Purity > 99% | S10196 | C16H36NO4P | 337,4 | 253678-65-8 |
| n-Dodecyl-phosphocholine (C12-PC) Purity > 99% | S10190 | C17H38NO4P | 351,46 | 29557-51-5 |
| n-Tridecyl-phosphocholine (C13-PC) Purity > 99% | S10198 | C18H40NO4P | 365,49 | 85775-42-4 |
| n-Tetradecyl-phosphocholine (C14-PC) Purity > 99% | S10194 | C19H42NO4P | 379,51 | 77733-28-9 |
| n-Pentadecyl-phosphocholine (C15-PC) Purity > 99% | S10199 | C20H44NO4P | 393,54 | 146801-07-2 |
| n-Hexadecyl-phosphocholine (C16-PC) Purity > 99% | S01241 | C21H46NO4P | 407,57 | 58066-85-6 |
| α-D-Galactopyranose-phosphate di-potassium salt dihydrate | P0001 | C6H11K2O9P. 2H2O | 372,36 | 19046-60-7 |
| α-D-Glucopyranose-phosphate di-potassium salt dihydrate | P0002 | C6H11K2O9P. 2H2O | 372,36 | 5996-14-5 |
| α-D-Mannopyranose-phosphate di-potassium salt dihydrate | P0003 | C6H11K2O9P. 2H2O | 372,36 | 71888-67-0 |
| N-Acetyl-D-galactosamine (2-Acetamido-2-deoxy-D-galactose, GalNAc) | S96001 | C8H15NO6 | 221,21 | 1811-31-0 |
| N-Acetyl-D-glucosamine (2-Acetamido-2-deoxy-D-glucose, GlcNAc) | S93002 | C8H15NO6 | 221,21 | 7512-17-6 |
| 2-Acetamido-2-deoxy-β-D-glucopyranosylamin | S98003 | C8H16N2O5 | 220,21 | 18615-50-4 |
| N-Acetyl-D-mannosamine x H2O (2-Acetamido-2-deoxy-D-mannose monohydrate, D-ManAc x H2O) | S94004 | C8H17NO7 | 239,23 | 7772-94-3 |
| 1,3,4,6-tetra-O-acetyl-β-D-GlcNAc (2-Acetamido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose) | S94005 | C16H23NO10 | 389.36 | 7772-79-4 |
| 3,4,6-tri-O-acetyl-β-D-GlcNAc azide (2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl azide) | S96006 | C14H20N4O8 | 372,34 | 6205-69-2 |
| 3,4,6-tri-O-acetyl-α-D-GlcNAc chlorid (2-Acetamido-2-deoxy-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranosyl chlorid) | S97007 | C14H20CINO8 | 366,80 | 3068-34-6 |
| 1,3,4,6-tetra-O-acetyl-α-D-glucosamine x HCl (2-Amino-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose HCl) | S00116 | C14H22CINO9 | 383,79 | N/A |
| Allyl 2-acetamido-2-deoxy-α-D-glucopyranoside | S96008 | C11H19NO6 | 261,28 | 54400-75-8 |
| Allyl 2-acetamido-2-deoxy-β-D-glucopyranoside | S96009 | C11H19NO6 | 261,28 | 54400-77-0 |
| Allyl α-D-galactopyranoside | S96010 | C9H16O6 | 220,22 | 48149-72-0 |
| Allyl α-D-glucopyranoside | S98011 | C9H16O6 | 220,22 | 7464-56-4 |
| Allyl β-D-glucopyranoside | S98012 | C9H16O6 | 220,22 | 34384-797 |
| Allyl α-D-mannopyranoside | S11118 | C9H16O6 | 220,22 | 41308-76-3 |
| Allyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside | S98013 | C30H34O6 | 490,60 | N/A |
| 1-Amino-1-deoxy-β-D-galactose (β-D-Galactopyranosylamine) | S99102 | C6H13NO5 | 179,17 | 50444-86-5 |
| 1,6-Anhydro-β-D-galactopyranose | S93014 | C6H10O5 | 162,14 | 644-76-8 |
| 1,6:3,4-Dianhydro-2-O-tosyl-β-D-galactopyranose | S97016 | C13H14O6s | 234,25 | 6167-32-4 |
| D-Arabinose | S93017 | C5H10O5 | 150,13 | 28697-53-2 |
| Arbutin (4-Hydroxyphenyl b-D-glucopyranoside, synthetic) | S96018 | C12H16O7 | 272,25 | 497-76-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-galactopyranose | S96021 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α,β-D-galactopyranose | S97022 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-β-D-glucopyranose | S96024 | C14H19N3O9 | 373,32 | N/A |
| 2-Azido-2-deoxy-1,2‘,3,3‘,4‘,6,6‘-hepta-O-acetyl-α,β-lactose 2-Azido-2-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-1,3,6-tri-O-acetyl-α,β-D-glucopyranose | S96025 | C26H35N3O17 | 661,58 | N/A |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-mannopyranose | S97026 | C14H19N3O9 | 373,32 | N/A |
| Benzyl 4,6-O-benzylidene-α-D-GlcNAc | S97027 | C22H25NO6 | 399,45 | 13343-63-0 |
| Benzyl α-D-GlcNAc (Benzyl 2-acetamido-2-deoxy-α-D-glucopyranoside) | S97028 | C15H21NO6 | 311,34 | 13343-62-9 |
| Benzyl α-D-mannopyranoside | S97029 | C13H18O6 | 270,28 | 155548-45-5 |
| Cellobiose | S96030 | C12H22O11 | 342,30 | 528-50-7 |
| 6-Deoxy-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose | S96032 | C12H20O5 | 244,29 | 4026-27-1 |
| 3,4-Di-O-acetyl-L-rhamnal (3,4-Di-O-acetyl-6-deoxy-L-glucal) | S94035 | C10H14O5 | 214.22 | 34819-86-8 |
| 1,4:3,6-Dianhydro-D-mannitol | S97037 | C6H10O4 | 146,15 | 641-74-7 |
| 1,2,3,4-Di-O-isopropylidene-α-D-galactopyranose | S95038 | C12H20O6 | 260.29 | 4064-06-6 |
| 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose | S00112 | C12H20O6 | 260,29 | 582-52-5 |
| 1,2:5,6-Di-O-isopropylidene-D-mannitol | S95039 | C12H22O6 | 262,31 | 1707-77-3 |
| 2,3:5,6-Di-O-isopropylidene-α-D-mannofuranose | S93040 | C12H20O6 | 260.29 | 14131-84-1 |
| 1,2:3,5-Di-O-isopropylidene-α-D-xylofuranose | S00110 | C11H18O5 | 230,26 | 20881-04-3 |
| D-Fucose (6-Deoxy-D-galactose) | S96042 | C6H12O6 | 164,16 [3615-37-0] | 3615-37-0 |
| L-Fucose (6-Deoxy-L-galactose) | S96043 | C6H12O6 | 164,16 | 2438-80-4 |
| D-Galactosamine x HCl | S95044 | C6H13NO5 x HCl | 215.64 | 1172-03-8 |
| D-Glucosamine x HCl | S93045 | C6H13NO5 x HCl | 215.64 | 66-84-2 |
| L-Glucose | S94046 | C6H12O6 | 180.16 | 921-60-8 |
| 2,3,3’,4,6,6’-Hexa-O-acetyl-lactal | S97036 | N/A | N/A | |
| 1,2-O-Isopropylidene-α-D-glucofuranose | S00113 | C9H16O6 | 220,22 | 18549-40-1 |
| Isopropyl-β-D-thiogalactoside IPTG (lactose based) | S02122-L | C9H18O5S | 238,31 | 367-93-1 |
| Isopropyl-β-D-thiogalactoside IPTG (on plant based) | S02122-P | C9H18O5S | 238,31 | 367-93-1 |
| 3,4-O-Isopropylidene-D-mannitol | S94048 | C9H18O6 | 222,22 | 369-84-4 |
| 1,2-O-Isopropylidene-α-D-xylofuranose | S00111 | C8H14O5 | 190,20 | 20031-21-4 |
| D-Lyxose | S96051 | C5H10O5 | 150,13 | 1114-34-7 |
| L-Lyxose | S96052 | C5H10O5 | 150,13 | 1949-78-6 |
| Maltose monohydrate | S98053 | C12H22O11H2O | 360,32 | 6363-53-7 |
| β-Maltose octaacetate | S98054 | C28H38O19 | 678,63 | 22352-19-8 |
| D-Mannose | S93057 | C6H12O6 | 180.16 | 3458-28-4 |
| L-Mannose | S94058 | C6H12O6 | 180.16 | 10030-80-5 |
| Methyl 4,6-O-benzylidene-β-D-galactopyranoside | S96060 | C14H18O6 | 282,30 | 6988-39-2 |
| Methyl 4,6-O-benzylidene-α-D-glucopyranoside | S97061 | C14H18O6 | 282,30 | 3162-96-7 |
| Methyl 4,6-O-benzylidene-β-D-glucopyranoside | S98062 | C14H18O6 | 282,30 | 6988-39-2 |
| Methyl 6-deoxy-α-L-mannopyranoside (Methyl a-L-rhamnopyranoside) | S96063 | C7H14O5 | 178,19 | 15814-59-2 |
| Methyl α-D-fucopyranoside | S96064 | C7H14O5 | 178,19 | 1128-40-1 |
| Methyl α-L-fucopyranoside | S96065 | C7H14O5 | 178,19 | 14687-15-1 |
| Methyl β-D-galactopyranoside | S96066 | C7H14O6 | 194,18 | 1824-94-8 |
| Methyl β-D-glucopyranoside hemihydrate | S96067 | C7H14O6 | 194,18 | 7000-27-3 |
| Methyl β-D-ribopyranoside | S97068 | C6H12O5 | 164,16 | 17289-61-1 |
| Methyl 2,3,5-tri-O-benzoyl-α-D-arabinofuranoside | S98069 | C27H24O8 | 476,49 | N/A |
| 1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranose | S95072 | C16H22O11 | 390,35 | 4163-60-4 |
| 1,2,3,4,6-Penta-O-acetyl-α-D-mannopyranose | S99070 | C16H22O11 | 390,35 | 4163-65-9 |
| D-Raffinose pentahydrate | S96074 | C18H32O16 5H2O | 594,53 | 17629-30-0 |
| L-Rhamnose monohydrate | S94075 | C6H14O6 | 182.17 | 10030-85-0 |
| D-Ribose | S93076 | C5H10O5 | 150.13 | 50-69-1 |
| L-Ribose | S93077 | C5H10O5 | 150.13 | 24259-59-4 |
| D-Tagatose | S93079 | C6H12O6 | 180.16 | 87-81-0 |
| α-D-Talose | S93080 | C6H12O6 | 180.16 | 2595-98-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl azide | S96081 | C14H19N3O9 | 373,32 | 13992-26-2 |
| 2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl bromide | S96082 | C14H19BrO9 | 411.21 | 3068-32-4 |
| 2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl azide | S96083 | C14H19N3O9 | 373,32 | 13992-25-1 |
| 2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide | S94084 | C14H19BrO9 | 411.21 | 572-09-8 |
| 1,3,4,6-Tetra-O-acetyl-β-D-mannopyranose | S97086 | C14H20O10 | 348,31 | 18968-05-3 |
| 2,3,4,6-Tetra-O-acetyl-α-D-mannopyranose | S97087 | C14H20O10 | 348,31 | N/A |
| 1,2,3,5-Tetra-O-acetyl-β-D-ribofuranose | S94088 | C13H18O9 | 318.28 | 13035-61-5 |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-galactopyranose | S94089 | C14H20O9S | 364.37 | N/A |
| 2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose | S94090 | C14H20O9S | 364.37 | 19879-84-6 |
| 2,3,4,6-Tetra-O-benzyl-α-D-galactopyranose | S96091 | C34H3606 | 540.66 | 5308-25-7 |
| 2,3,4,6-Tetra-O-benzyl-α-D-glucopyranose | S93092 | C34H3606 | 540.66 | 4132-28-9 |
| 2,3,4,6-Tetra-O-benzyl-α-D-mannopyranose | S96093 | C34H3606 | 540.66 | 61330-61-8 |
| 1-Thio-β-D-galactose sodium salt | S96094 | C6H11NaO5S | 218,21 | 42891-22-5 |
| 1-Thio-β-D-glucose sodium salt dihydrate | S94095 | C6H11NaO5S x 2 H2O | 254.24 | 10593-29-0 |
| 3,4,6-Tri-O-acetyl-D-galactal | S94097 | C12H16O7 | 272.26 | 4098-06-0 |
| D-Turanose (α-D-Glcp(1-3)-D-fructose) | S93100 | C12H22O11 | 342.30 | 547-25-1 |
| D-Xylose | S93101 | C5H10O5 | 150.13 | 58-86-6 |
| 1,6-Anhydro-β-D-glucopyranose (Levoglucosan) | S93015 | C6H10O5 | 162,14 | 498-07-7 |
| 2-Azido-2-deoxy-1,3,4,6-tetra-O-acetyl-α-D-glucopyranose | S96023 | C14H19N3O9 | 373,32 | N/A |
我们承诺:
(1)专业的服务:为您提供包括购买咨询、技术支持及实验方案制定在内的全方位服务;
(2)迅捷的货期:利用国际化的物流平台,大大缩短产品从厂家到最终用户的时间;
(3)过硬的品质:确保正品、质量和售后,多年客户积累,口碑保证。
公司简介:
艾美捷科技有限公司经营范围涵盖分子生物学试剂、免疫学试剂、细胞生物学试剂、蛋白质研究试剂、微生物学试剂、化学及生化试剂、材料学试剂、天然提取物、仪器设备等9大门类,累计约10万余种产品,充分满足不同客户的个性化需求;公司代理国外50余种一线品牌试剂,以“高性价比、迅捷的物流速度、专业的技术支持”,让客户充分享受全球化带来的便利;公司还增加了基因编辑、蛋白表达、细胞鉴定等定制项目,大大提升了为客户服务能力。“不忘初心,方得始终”,艾美捷科技将继续秉持“专心、专业、为您”的宗旨,以客户为根本,以诚信为基础,持续地为各界客户提供更加优质的产品和服务。
Glycon Biochemicals GmbH; Glycon Biochem; Glycon; S20031; S97085; S10191; S10192; S10189; S03293; S05174; S02174; D-20054; D-20055; D-20056; D97011; D20034; D99014; D07033; D97001; D97001-C; D99011; D99011-C; D99006; D11023; D99007; D99019-C; D99020; D20018; D14001; D20020; D20015; D20015-C; D99003; D99003-C; D99012; D99012-C; D97002-C; D20016; D20016-C; D20028-C; D20040-C; D20029-C; D97002; S02122; D99013; D20014; D14038-C; D20021; D20022-C; D99013-C; D20014-C; D98004; D99005; D99008; D20038; D20041; D20033; D20035; D20039; D20032; D20031; D20030; D71111; S98001; D20036; D99009; D99010; S10197; S10195; S10196; S10190; S10198; S10194; S10199; S01241; P0001; P0002; P0003; S96001; S93002; S98003; S94004; S94005; S96006; S97007; S00116; S96008; S96009; S96010; S98011; S98012; S11118; S98013; S99102; S93014; S97016; S93017; S96018; S96021; S97022; S96024; S96025; S97026; S97027; S97028; S97029; S96030; S96032; S94035; S97037; S95038; S00112; S95039; S93040; S00110; S96042; S96043; S95044; S93045; S94046; S97036; S00113; S02122-L; S02122-P; S94048; S00111; S96051; S96052; S98053; S98054; S93057; S94058; S96060; S97061; S98062; S96063; S96064; S96065; S96066; S96067; S97068; S98069; S95072; S99070; S96074; S94075; S93076; S93077; S93079; S93080; S96081; S96082; S96083; S94084; S97086; S97087; S94088; S94089; S94090; S96091; S93092; S96093; S96094; S94095; S94097; S93100; S93101; S93015; S96023; 10030-80-5; 10030-85-0; 10593-29-0; 106402-05-5; 106402-05-5; 111-03-5; 1114-34-7; 1128-40-1; 115457-83-5; 116183-64-3; 1172-03-8; 13035-61-5; 13343-62-9; 13343-63-0; 13992-25-1; 13992-26-2; 14131-84-1; 146801-07-2; 14687-15-1; 148565-58-6; 155548-45-5; 15814-59-2; 1643-20-5; 1707-77-3; 17289-61-1; 17629-30-0; 1811-31-0; 1824-94-8; 18449-82-6; 18549-40-1; 18615-50-4; 18968-05-3; 19046-60-7; 19327-39-0; 1949-78-6; 19879-84-6; 20031-21-4; 20881-04-3; 22352-19-8; 24259-59-4; 2438-80-4; 25339-99-5; 253678-64-7; 253678-65-8; 253678-67-0; 253678-67-0; 2595-98-4; 26183-52-81; 28697-53-2; 29557-51-5; 29781-80-4; 29836-26-8; 29836-26-8; 3055-98-9; 3055-99-0; 3068-32-4; 3068-34-6; 3162-96-7; 34384-797; 3458-28-4; 34819-86-8; 3615-37-0; 367-93-1; 367-93-1; 367-93-1; 369-84-4; 4026-27-1; 4064-06-6; 4098-06-0; 41308-76-3; 4132-28-9; 4163-60-4; 4163-65-9; 48149-72-0; 497-76-7; 498-07-7; 50444-86-5; 50-69-1; 5168-89-8; 5274-68-0; 528-50-7; 5308-25-7; 54400-75-8; 54400-77-0; 547-25-1; 572-09-8; 58066-85-6; 582-52-5; 58846-77-8; 58-86-6; 59080-45-4; 59122-55-3; 5996-14-5; 61330-61-8; 6167-32-4; 6205-69-2; 6363-53-7; 641-74-7; 644-76-8; 6540-99-4; 66-84-2; 69227-93-6; 69227-93-6; 6988-39-2; 6988-39-2; 69984-73-2; 69984-73-2; 7000-27-3; 70005-86-6; 70504-28-8; 71888-67-0; 7464-56-4; 7512-17-6; 75621-03-3; 7772-79-4; 7772-94-3; 77733-28-9; 78617-12-6; 82473-24-3; 82494-08-4; 82494-09-5; 82494-09-5; 85261-19-4; 85261-19-4; 85316-98-9; 85618-20-8; 85618-20-8; 85618-21-9; 85618-21-9; 85775-42-4; 870287-95-9; 87-81-0; 9043-30-5; 921-60-8; 93911-12-7; 93911-12-7; 98064-96-1; 98854-15-0; 98854-16-1

艾美捷科技代理MegaZyme品牌
Megazyme 成立于1988年,位于爱尔兰,是一家全球知名的酶及酶法分析试剂盒的生产厂家,专注于制造和供应高品质和创新的检测试剂盒和生化分析试剂。Megazyme 产品线以其卓越的高纯度酶制剂而闻名,是全球多种碳水化合物及酶底物产品的核心供应商。该公司目前提供了超过70种诊断试剂盒和超过300种其他试剂和底物。
Megazyme产品广泛应用的领域:
1)食品和饮料:用于检测和分析食品中的成分和添加剂。
2)生物燃料:用于生物燃料的开发和生产过程中的质量控制。
3)动物饲料:确保饲料成分的安全和营养价值。
4)葡萄酒和酿造:用于葡萄酒的发酵和质量控制。
5)乳制品和谷类食品:用于乳制品和谷类食品的营养成分分析。

Megazyme产品线包括:
● 检测试剂盒:涵盖膳食纤维、淀粉、糖类、醇类、有机酸、酶活性等领域;
● 高纯度酶制剂与生化底物:生产供应种类繁多的高纯度酶,包括:碳水化合物水解酶、氧化还原酶、蛋白酶 & 脂肪酶以及其他特异性酶。此外,Megazyme还提供各种高纯度的酶作用底物,特别是碳水化合物底物;
● 分析标准品与参比物质:提供与检测试剂盒配套或独立的高纯度、认证的分析标准品,包括分析标准缓冲液,辅助因子与染色剂等;
● 配套仪器与自动化解决方案:Megazyme 也开发或整合了部分专用仪器,用于高通量处理特定检测 (如膳食纤维) 中的复杂步骤。

艾美捷科技代理Hampton Research品牌产品。
Hampton Research是一家专注于蛋白质结晶和相关生命科学工具的公司,作为蛋白质结晶领域的重要供应商,Hampton Research提供广泛的产品和服务,帮助科学家在结构生物学、药物开发和生物化学研究中实现高质量的晶体生长,特别是在 X 射线晶体学和冷冻电镜(Cryo-EM)领域。Hampton Research公司主要产品类别包括:
(1)结晶筛选试剂盒
Crystal Screen™ 系列,提供多种结晶条件筛选试剂盒,适用于初步筛选和优化结晶条件。
Index™ 试剂盒,包含广泛的化学条件,用于快速筛选结晶条件。
SaltRx™ 试剂盒,专注于盐类结晶条件的筛选。
PEG/Ion™ 试剂盒,提供基于聚乙二醇(PEG)和离子溶液的结晶条件。
(2)结晶优化试剂
Additive Screen™,包含多种添加剂,用于优化晶体生长。
Crystal CryoProtection™ 试剂,用于保护晶体在低温条件下的完整性。
PEG 溶液和缓冲液,提供不同分子量和浓度的 PEG 溶液,用于结晶实验。
(3)结晶工具和设备
Crystallization Plates,提供多种规格的结晶板,如 24 孔、96 孔和 384 孔板,适用于高通量筛选。
CrystalCap™ 帽盖,用于密封结晶板,防止样品蒸发和污染。
CrystalMiner™ 机器人,自动化结晶实验设备,提高实验效率和一致性。
(4)蛋白质结晶相关试剂
Protein Stabilization Reagents,用于稳定蛋白质样品,提高结晶成功率。
Detergent Screen™,包含多种去污剂,用于膜蛋白结晶。
Nucleation Reagents,促进晶体成核,提高结晶效率。

艾美捷科技代理JGFInneran品牌。
JGFInneran在生物技术和实验室设备领域具有显著优势,凭借高质量产品和定制化服务,赢得了广泛的市场认可。JGFInneran提供先进的控制系统,实现精确的温度、pH、溶氧控制;采用高质量材料,使用不锈钢和玻璃等耐腐蚀材料,确保设备耐用;自动化与数据记录: 支持自动化操作和实时数据记录,便于实验监控和分析。应用领域包括:生物制药: 用于单克隆抗体、疫苗等生产;生物燃料: 用于微生物发酵生产乙醇等;食品与饮料: 用于发酵工艺优化;学术研究: 为科研机构提供实验设备。
JGFInneran公司主要产品包括:
(1)生物反应器:用于细胞培养和发酵,广泛应用于生物制药、疫苗生产和生物燃料开发。
(2)发酵罐:适用于微生物和细胞培养,具备高精度控制和自动化功能。
(3)实验室设备:提供搅拌器、泵、传感器等,满足实验室的多样化需求。
(4)定制解决方案:根据客户需求,提供定制化的生物反应器和发酵罐。

艾美捷科技代理Quartett品牌
Quartett公司于1986年在德国柏林创立,始终致力于癌症防治领域并推动肿瘤诊断技术革新。quartett专注于两大核心业务:为解剖病理学/免疫组化(IHC)领域生产单克隆抗体,同时为制药工业及科研机构提供合成多肽产品。
▍Quartett两大核心技术
● 兔源重组单克隆抗体技术平台:突破传统鼠源抗体的局限。相较于鼠类免疫系统,兔源免疫系统具有显著优势——可识别更微小表位(≤5个氨基酸)、产生亲和力达10⁻¹²M的高特异性抗体,这使得quartett公司开发的诊断试剂在癌症检测中展现出卓越性能(如PD-L1检测灵敏度92.7%)。
● 合成肽制备技术:专业生产HPLC纯度>95%的定制肽,包括蛋白酶抑制剂及抗体生产用免疫原肽。该平台的成功更直接推动了兔源重组抗体技术的突破性发展,形成从合成肽到高价值诊断抗体的完整技术闭环。所有试剂均优化适配全自动染色平台(如Roche Ventana/Leica BOND)及人工染色流程。

▍Quartett部分产品列表
| 品名 | 货号 | Application | Host | Subclass | 规格 |
| CD31 (QR034) | C-C031-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| ERG (QR040) | C-E003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Arginase-1 (QR083) | C-A003-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cadherin 17(QR098) | C-C036-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CD117 (QR012) | P-C003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| CD171/L1CAM (QR039) | C-C025-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| CDX2 (QR045) | P-C016-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 20 (Ks20.8) | C-C005-01 | IHC (FFPE) | Mouse | IgG2a/k | 0.1 ml concentrate |
| Glutamine synthetase (QR090) | P-G003-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Glypican 3 (QR103) | C-G005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| HSP70 (QR087) | P-H002-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MLH1 (QM003) | C-M001-01 | IHC (FFPE) | Mouse | IgG2a/IgK | 0.1 ml concentrate |
| MSH2 (QR010) | P-M004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| MSH6 (QR011) | C-M005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| PMS2 (QR009) | P-P005-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| SATB2 (QR023) | C-S002-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| SMAD4 (QR029) | P-S007-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| BAP1 (QR119) | C-B005-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 14 (QR057) | P-C033-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5 (QR027) | C-C008-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 5/14 (QR027/QR057) | P-C035-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 5/6 (QR027/QR028) | C-C017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 6 (QR028) | C-C009-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin 7 (QR049) | P-C014-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Cytokeratin 8 (QR112) | C-C040-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| Cytokeratin pan (MNF-116) | P-C034-150 | IHC (FFPE) | Mouse | IgG1/k | 15 ml Ready to use |
| EpCAM (QR107) | C-E006-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| GLUT1 (QR082) | P-G004-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| Inhibin alpha (QR088) | C-I004-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| NUT (QR043) | P-N001-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
| p21 (QR085) | C-P017-01 | IHC (FFPE) | Rabbit | IgG | 0.1 ml concentrate |
| p53 (QR025) | P-P011-150 | IHC (FFPE) | Rabbit | IgG | 15 ml Ready to use |
<艾美捷科技代理RA Biosources品牌全系列产品
RA Biosources,Inc.是由郭博士于2003年1月在美国加利福尼亚州贝尔蒙特创立的一家生物技术公司,专注于开发作为体外诊断试剂的单克隆抗体。经过多年的发展,RA Biosources公司产品线包括癌症标志物、滥用药物、传染源、胶原蛋白和细胞外基质蛋白、激素以及血清蛋白等。这显示了公司在生物技术研发方面的深厚实力和广泛覆盖。

▍RA Biosources部分产品列表
| 货号 | 同种型 | 品名 | 产品描述 |
| MA011 | IgG1 | Monoclonal Anti-human Alpha Fetoprotein (AFP) | This antibody reacts with AFP. There is no cross reactivity with human albumin, CEA, ferritin, hCG and PSA |
| MB034 | IgG1 | B2 Microglobulin | This antibody is specific to human beta-2 microglobulin |
| MC091 | IgG1 | Monoclonal Anti-CA12-5 | This antibody reacts with CA12-5 |
| MC123 | IgG1 | Monoclonal Anti-CA72-4 | This antibody reacts with CA72-4 |
| MC021 | IgG1 | Monoclonal Anti-human Carcinoembryonic Antigen (CEA) | This antibody reacts with CEA. There is no cross reactivity with human NCA, hCG and PSA |
| MF016 | IgG1 | Monoclonal Anti-human Ferritin | This antibody reacts with human ferritin |
| MG021 | IgG1 | Monoclonal Anti-human Growth Hormone (HGH) | This antibody reacts with human growth hormone |
| MP081 | IgG1 | Monoclonal Anti-Prostate Acid Phosphatase (PAP) | Specific to PAP |
| MP015 | IgG1 | Monoclonal Anti-human Prostate Specific Antigen (PSA) | This antibody reacts with free PSA and PSA-ACT (PSA-alpha 1-antichymotrypsin) complex. There is no cross reactivity with human kallikrein and ACT |
| MP016 | IgG1 | Monoclonal Anti-human PSA-ACT | This antibody reacts with PSA-ACT. There is no cross reactivity with free PSA and ACT |
| MP014 | IgG1 | Monoclonal Anti-human Free Prostate Specific Antigen (fPSA) | This antibody reacts only with free PSA. There is no cross reactivity with PSA-ACT, human kallikrein, or ACT |
| MC035 | IgG2a | Monoclonal Anti-Human Collagen Type IV | This antibody is specific to human collagen type IV |
| ML021 | IgG1 | human laminin | This antibody is specific to human laminin. It does not react with mouse laminin. |
| MF023 | IgG1 | Monoclonal Anti-Human Fibronectin | This antibody is specific to human fibronectin |
| ML031 | IgG1 | Monoclonal Anti-Mouse Laminin | This antibody is specific to mouse laminin. It does not react with human laminin. |
| MM102 | IgG1 | Monoclonal 6-Monoacetylmorphine (6MAM) | Mab to 6MAM |
| MA041 | IgG1 | Monoclonal AB-Pinaca | Mab to AB-Pinaca |
| MA022 | IgG2b | Monoclonal Anti-Amphetamine | Mab to amphetamine |
| MB011 | IgG1 | Monoclonal Anti-Barbiturates | Mab to barbiturates |
| MB021 | IgG1 | Monoclonal Anti-Benzoylecgonine | This antibody reacts with benzoylecgonine |
| MC082 | IgG1 | Monoclonal Anti-Clonazepam | This antibody reacts with clonazepam and 7-clonazepam |
| MC011 | IgG1 | Monoclonal Anti-Cotinine | Specific to cotinine |
| ME012 | IgG1 | Monoclonal Anti-EDDP | This antibody reacts with EDDP |
| MF041 | IgG1 | Monoclonal Anti-Fentanyl | Mab to fentanyl |
| MK015 | IgG1 | Monoclonal Anti-K2 | Mab to K2 |
| MK021 | IgG2b | Monoclonal Anti-Ketamine | Mab to ketamine |
| ML041 | IgG1 | Monoclonal Anti-Lysergic acid diethylamide (LSD) | Mab to LSD |
| MM091 | IgG1 | Monoclonal Anti-Melatonin | Mab to Melatonin |
| MM011 | IgG1 | Monoclonal Anti-Methadone | This antibody reacts with methadone |
| MM031 | IgG1 | Monoclonal Anti-Methylenedioxymethamphetamine (MDMA) | Mab to MDMA |
| MM063 | IgG1 | Monoclonal Anti-Methamphetamine | Mab to methamphetamine |
| MM111 | IgG1 | Monoclonal Anti-Methaqualone | This antibody reacts with methaqualone |
| MM071 | IgG2a | Monoclonal Anti-Methcathinone | Mab to methcathinone |
| MM083 | IgG1 | Monoclonal Anti-Methotrexate | Mab to methotrexate |
| MM041 | IgG1 | Monoclonal Anti-Morphine | This antibody reacts with morphine |
| MO022 | IgG1 | Monoclonal Anti-Oxycodone | This antibody reacts with oxycodone |

艾美捷科技代理Biothema品牌。
Biothema是一家专注于酶学和临床诊断的公司,提供高质量的酶制剂和生物化学试剂,广泛应用于临床诊断、食品检测和生物研究。Biothema公司采用先进的生产和纯化技术,确保酶制剂的高纯度和高活性;产品广泛应用于临床诊断、食品检测和生物研究;提供灵活的定制酶制剂和试剂开发服务,满足客户需求。
Biothema公司主要产品与服务包括:
(1)酶制剂:提供多种高纯度的酶制剂,包括氧化酶、脱氢酶和过氧化物酶。
(2)临床诊断试剂:提供用于临床诊断的试剂盒,包括血糖、胆固醇和乳酸检测试剂盒。
(3)生物化学试剂;提供多种生物化学试剂,用于食品检测、环境监测和生物研究。
(4)定制服务:根据客户需求,提供定制化的酶制剂和试剂开发服务。
<艾美捷科技代理A/F Protein品牌全系列产品
A/F Protein Inc成立于1994年,专注于从天然来源纯化防冻蛋白,并销售给研发界。防冻蛋白的研究始于1950年代,当时科学家发现一些鱼类能够在极低温度下生存而不被冻结,因为它们血液中含有一种能够降低冰点的化合物,即防冻蛋白。A/F Protein在防冻蛋白领域取得了显著成就,拥有多项控制AFP(防冻蛋白)重要用途的专利。这些专利涵盖了防冻蛋白在哺乳动物细胞、组织和器官低温保存中的应用,以及使用防冻蛋白冷冻消融人类肿瘤细胞等领域。A/F Protein公司的产品包括I型和III型防冻蛋白以及防冻糖蛋白。这些蛋白质都是从天然来源纯化的冷海洋硬骨鱼中提取的,以干燥形式出售。

▍A/F Protein应用前景
A/F Protein的防冻蛋白和糖蛋白具有广泛的应用前景:
● 长效低温血小板保存液:含抗冻蛋白溶液,用于延长血小板在低温条件下的储存时间
● 肿瘤冷冻消融增效剂:提升冷冻手术治疗人体肿瘤效果的蛋白溶液
● 器官移植保存液:用于心脏/肾脏等移植器官的 低温-超低温保存技术
● 辅助生殖细胞保存液:试管婴儿所需的卵子与精子 超低温保存解决方案
● 动物生殖细胞保存技术:兽医学用动物卵母细胞及胚胎冷冻保存液
● 抗冻蛋白护肤产品:针对寒冷环境的 蛋白基护肤配方,增强皮肤防护力
● 食品加工保鲜技术:基于抗冻蛋白的食品质构改良与冷冻保鲜工艺
● 科研级纯化抗冻蛋白:高纯度抗冻蛋白试剂,供实验室研发使用

Diapharma Group INC成立于1997年,研究人员具有多年临床以及研发经验,专注于血液病领域的试剂盒,试剂以及仪器,主要涵盖血栓形成、止血、血小板功能分析、细胞凋亡、生态毒理学等。"
Diapharma Group, Inc. in West Chester, Ohio sells hemostasis, thrombosis, platelet function testing, instrumentation, and apoptosis products in the diagnostic and research fields and provides strong technical competence and experience to ensure customer expectations will be met or exceeded.
DiaPharma Group的主要产品包括:
CK18 Biomarkers & Others
Apoptosis & Necrosis
Toxicology
Oncology
Hepatology
Hemostasis
Chromogenic Substrates
Coagulation Kits
Anticoagulation Monitoring Kits
Fibrinolysis Kits
Hemostasis Autoimmunity
Calibrators & Controls
Enzymes & Other Proteins
Buffers & Diluents
Factor Deficient Plasmas
Inhibitor Plasmas
Phospholipids
Antibodies
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://novatein.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="diapharma"> diapharma

艾美捷科技代理Pluriselect品牌。
PluriSelect Life Science是一家德国生物技术公司,为免疫学、基础科学和诊断领域的研究提供细胞和蛋白质分离优化产品。
Pluriselect细胞过滤器的特点:
1)提供种类繁多的细胞过滤器,几乎可以满足所有需求
2)是市场上细胞过滤器之一,具有许多附加功能,而大多数类似的基本细胞过滤器(如Falcon™或EASYstrainer™)都没有这些功能。
3)有19种网眼尺寸可供选择,适用于需要过滤和净化液体的各种实验室应用。
4)具有流量控制功能(与连接器环结合)的经济实惠的细胞过滤器系统的最佳选择
5)pluriStrainer®Mini是几乎所有反应管(15ml至1.5ml,24/48孔板)中最灵活的小型细胞过滤器配件
6)独特的设计可改善通风,避免堵塞,从而实现智能样品制备。
7)pluriStrainer®可堆叠,以允许使用不同的网目尺寸进行直接过滤,也可以倒置以回收筛分的材料,对于大样本量,它可以与漏斗结合使用。

Pluriselect细胞过滤器
1)消化乳腺组织和类器官后获得真正的单细胞悬浮液
2)使用pluriBead技术富集特定细胞
3)骨髓、胰腺、胸腺、淋巴结等血细胞的单细胞悬液的制备
4)细胞与其他原代组织的解离
5)流式细胞术用真实单细胞悬液的制备(FACS™)
6)纱布过滤的更快、更简单的替代品
7)复杂和粘性液体的筛分(与真空连接环和注射器结合使用)
8)细胞/细胞因子的短时间孵育(与pluriBead和连接环结合)
产品列表如下:
<| 品名 | 货号 | 规格 |
| pluriStrainer 100µm, PET-mesh, 50 pcs, sterile | 43-50100-51 | 50 pcs |
| pluriStrainer Mini, 10µm, 50pcs, 25pcs sterile in bag | 43-10010-50 | 50pcs |
| pluriStrainer 15µm, 25 pcs, sterile | 43-50015-03 | 25 pcs |
| pluriStrainer 20µm, 25 pcs, sterile | 43-50020-03 | 25 pcs |
| pluriStrainer 300µm, 25 pcs, sterile | 43-50300-03 | 25 pcs |
| pluriStrainer 500µm, 25 pcs, sterile | 43-50500-03 | 25 pcs |
| Funnel, 25 pcs, sterile | 42-50000-03 | 25 pcs |
| pluriStrainer 30µm, 25 pcs, sterile | 43-50030-03 | 25 pcs |
| pluriStrainer 400µm, 50 pcs - non-sterile | 43-50400-50 | 50 pcs |
| pluriStrainer Mini 8 µm (membrane, 5 pcs.), sterile | 46-10008-15 | 5 pcs |
| CD3 S-pluriBead anti-hu, 2ml | 19-00300-10 | 2ml |
| Centrifuge Tube 15 ml (sterile, 50 pcs.) | 05-00002-50 | 50 pcs |
| pluriSpin Human Monocyte Enrichment, 2ml | 19-01001-31 | 2ml |
| CD11a M-pluriBead anti-hu, 2ml | 19-011a0-20 | 2ml |
| Centrifuge Tube 50 ml (sterile, 300 pcs.) standing edge | 05-00004-01 | 300 pcs |
| pluriSpin Human T Cell Enrichment, 2ml | 19-02001-31 | 2ml |
| pluriSpin Human T Cell Depletion, 2ml | 19-02002-31 | 2ml |
| pluriSpin Human CD8+ T Cell Enrichment, 2ml | 19-04001-31 | 2ml |
| pluriSpin Human CD8+ Cell Depletion, 2ml | 19-04002-31 | 2ml |
| pluriSpin Human CD4? Cell Depletion, 2ml | 19-03002-31 | 2ml |
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:13212737804
邮箱:sales@amyjet.com
0.1516